Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus
Por um escritor misterioso
Descrição
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
Dual-target Janus kinase (JAK) inhibitors: Comprehensive review on the JAK-based strategies for treating solid or hematological malignancies and immune-related diseases - ScienceDirect
TK4g is a JAK Inhibitor for Leukemia Cancer Research
Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy, Cell Communication and Signaling
Design, Synthesis, Activity Evaluation and Molecular Docking Study of Novel Janus kinase Inhibitors - Du - 2021 - ChemistrySelect - Wiley Online Library
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
Synthesis of Glycodendrimers with Antiviral and Antibacterial Activity - Hoyos - 2021 - Chemistry – A European Journal - Wiley Online Library
Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections
Frontiers Immunomodulation—a general review of the current state-of-the-art and new therapeutic strategies for targeting the immune system
Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors - ScienceDirect
Molecules, Free Full-Text
Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin
The JAK/STAT signaling pathway: from bench to clinic
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation
de
por adulto (o preço varia de acordo com o tamanho do grupo)